Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial. (Q48364637)
Jump to navigation
Jump to search
scientific article published on 23 January 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial. |
scientific article published on 23 January 2014 |
Statements
1 reference
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial. (English)
1 reference
Ludwig Kappos
1 reference
Giancarlo Comi
1 reference
Christian Confavreux
1 reference
Paul O'Connor
1 reference
Mark S Freedman
1 reference
Aaron E Miller
1 reference
Tomas P Olsson
1 reference
Jerry S Wolinsky
1 reference
Teresa Bagulho
1 reference
Jean-Luc Delhay
1 reference
Deborah Dukovic
1 reference
Philippe Truffinet
1 reference
TOWER Trial Group
1 reference
23 January 2014
1 reference
1 reference
13
1 reference
247-256
1 reference
3
1 reference
Identifiers
1 reference
1 reference